<DOC>
	<DOCNO>NCT01673880</DOCNO>
	<brief_summary>This single-center , open-label , randomize crossover study conduct three cohort healthy adult subject . Approximately 36 subject randomize one three cohort ( approximately 12 subject per cohort ) receive single dose E2006 capsule formulation single dose E2006 tablet formulation , random sequence , 1:1 ratio . The dos test 2.5 mg , 10 mg , 25 mg .</brief_summary>
	<brief_title>Open-Label Study Bioavailability E2006 Tablet Versus Capsule Formulations</brief_title>
	<detailed_description />
	<criteria>Inclusion : Healthy male female , age 18 55 year Body mass index ( BMI ) &amp; gt ; 18 32 kg/m2 Screening Exclusion : Female subject nursing Subjects history gastrointestinal surgery ( hepatectomy , nephrectomy , digestive organ resection , etc . ) may affect PK profile E2006 Subjects know history clinically significant drug food allergy Subjects know allergy hypersensitivity capsule tablet ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>